Comparison
3 Methylglutaconic Aciduria With Deafness Encephalopathy And Leigh Like Syndrome C4040739 vs 17p11 2 Microduplication Syndrome C2931246
Clinical comparison between 3 Methylglutaconic Aciduria With Deafness Encephalopathy And Leigh Like Syndrome and 17p11 2 Microduplication Syndrome for differential diagnosis and treatment planning.
3 Methylglutaconic Aciduria With Deafness Encephalopathy And Leigh Like Syndrome C4040739
A severe mitochondrial disorder affecting the brain, hearing, and energy metabolism. It causes progressive neurological decline, hearing loss, and metabolic problems. Management requires intensive supportive care.
17p11 2 Microduplication Syndrome C2931246
A chromosomal condition involving duplication on chromosome 17, related to Potocki-Lupski syndrome. Features often include developmental delays, learning challenges, and distinctive facial features.
6 comparison axes
Onset
3 Methylglutaconic Aciduria With Deafness Encephalopathy And Leigh Like Syndrome C4040739
0-5
17p11 2 Microduplication Syndrome C2931246
0-null
Onset patterns differ
Severity
3 Methylglutaconic Aciduria With Deafness Encephalopathy And Leigh Like Syndrome C4040739
severe
17p11 2 Microduplication Syndrome C2931246
moderate
Different severity levels
Chronic
3 Methylglutaconic Aciduria With Deafness Encephalopathy And Leigh Like Syndrome C4040739
Chronic
17p11 2 Microduplication Syndrome C2931246
Chronic
Differing course
Communicable
3 Methylglutaconic Aciduria With Deafness Encephalopathy And Leigh Like Syndrome C4040739
No
17p11 2 Microduplication Syndrome C2931246
No
Different transmission
Body System
3 Methylglutaconic Aciduria With Deafness Encephalopathy And Leigh Like Syndrome C4040739
metabolic
17p11 2 Microduplication Syndrome C2931246
congenital
Same/different system
Category
3 Methylglutaconic Aciduria With Deafness Encephalopathy And Leigh Like Syndrome C4040739
metabolic
17p11 2 Microduplication Syndrome C2931246
genetic
Different category
Bottom line
3-methylglutaconic-aciduria-with-deafness-encephalopathy-and-leigh-like-syndrome-C4040739 and 17p11-2-microduplication-syndrome-C2931246 differ in severity, etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | 3 Methylglutaconic Aciduria With Deafness Encephalopathy And Leigh Like Syndrome C4040739 | 17p11 2 Microduplication Syndrome C2931246 | Discriminating power |
|---|---|---|---|
| Neurologic course | Progressive encephalopathy and Leigh-like features may occur. | Developmental delay or learning difficulty is more typical than progressive encephalopathy. | High |
| Hearing | Sensorineural hearing loss is a recognized feature. | Hearing loss is not a defining feature in the supplied description. | Moderate |
| Metabolic findings | Abnormal energy metabolism and 3-methylglutaconic aciduria may be present. | No characteristic organic aciduria is established by the supplied data. | High |
When to favor each condition
Choose 3 Methylglutaconic Aciduria With Deafness Encephalopathy And Leigh Like Syndrome C4040739 when
Infant or young child with progressive neurologic decline
Fits the described severe mitochondrial presentation better than a stable chromosomal phenotype.
Moderate
Hearing loss with encephalopathy and metabolic abnormality
The combination aligns with the named left syndrome, but confirmation is required.
Moderate
Leigh-like imaging or clinical pattern
Supports consideration of the left disorder rather than microduplication syndrome.
Moderate
Choose 17p11 2 Microduplication Syndrome C2931246 when
Developmental delay with distinctive facial features
Matches the supplied chromosomal syndrome description more closely.
Moderate
Suspected genomic copy-number disorder
A 17p11.2 duplication is a chromosomal finding, not a mitochondrial aciduria.
High
Learning challenges without progressive metabolic encephalopathy
The right condition is described as moderate and developmental rather than rapidly progressive.
Low
How key tests differ
| Test | 3 Methylglutaconic Aciduria With Deafness Encephalopathy And Leigh Like Syndrome C4040739 | 17p11 2 Microduplication Syndrome C2931246 | Interpretation |
|---|---|---|---|
| Urine organic acids | May show 3-methylglutaconic aciduria; exact cutoffs are not established here. | No characteristic organic acid pattern is established. | An abnormal result supports metabolic evaluation but is not itself a complete diagnosis. |
| Chromosomal microarray | Not expected to define this mitochondrial disorder. | May identify a 17p11.2 microduplication. | A duplication finding supports the right diagnosis when clinically correlated. |
| Mitochondrial or targeted genetic testing | May be used to investigate the suspected mitochondrial syndrome. | Not the primary test for a chromosomal microduplication. | Test choice depends on phenotype; negative results do not exclude all genetic causes. |
Prognosis comparison
3 Methylglutaconic Aciduria With Deafness Encephalopathy And Leigh Like Syndrome C4040739
- Outcome
- Often severe and progressive, but exact survival or disability rates are not established here.
- Factors
- Neurologic progression, metabolic instability, hearing loss, and supportive-care needs may influence outcome.
17p11 2 Microduplication Syndrome C2931246
- Outcome
- Generally described as moderate, with developmental and learning challenges; individual course varies.
- Factors
- Degree of developmental delay, learning needs, associated anomalies, and access to support may matter.
Time frame: Both are chronic; the left condition is described with early childhood onset, while right onset timing is not fully specified.
Genetic confirmation, clinical severity, complications, and supportive care influence outlook. No definitive prognosis is established.
Complications comparison
| Complication | Presentation |
|---|---|
| Neurologic decline | Progressive neurologic impairment may be severe. Developmental and learning difficulties are described; progressive decline is not established. Course differs, but individual outcomes vary and require specialist follow-up. |
| Hearing impairment | Hearing loss is part of the syndrome description. Not established as a core complication from the supplied data. Audiology needs should be individualized. |
| Support needs | Intensive supportive care may be required. Educational and developmental support are commonly relevant. Neither description establishes specific treatment doses or protocols. |
Patient education highlights
- HighDistinct conditions
These conditions have different causes: mitochondrial disease versus a chromosome 17 duplication. A test result alone should be interpreted by a clinician.
- HighUrgent changes
New seizures, breathing difficulty, reduced alertness, or feeding failure need urgent medical assessment, especially if a mitochondrial disorder is suspected.
- MediumSupport planning
Hearing, development, learning, nutrition, and therapy needs should be reviewed regularly. Prognosis cannot be predicted from this comparison alone.